Literature DB >> 33466356

Predictive Effect of Helicobacter pylori in Gastric Carcinoma Development: Systematic Review and Quantitative Evidence Synthesis.

Laurens Holmes1,2, Jasmine Rios1,3, Betyna Berice1,4, Jacqueline Benson1,5, Nastocia Bafford1, Kadedrah Parson1, Daniel Halloran1,2.   

Abstract

Helicobacter pylori (H. pylori) is a bacterial pathogen implicated in gastritis, gastric ulceration, and gastric carcinoma. This study aimed to synthesize literature in providing evidence on the causative role of H. pylori in gastric carcinoma development. This study is based on assessing public literature using an applied meta-analysis, namely, quantitative evidence synthesis (QES). The analytic procedure uses DerSimonian-Laird, including assessing heterogeneity. The QES also utilizes meta-regression and the environmental effect associated with H. pylori in gastric cancer development. Eighteen studies are included in the QES. There is increased prevalence of H. pylori exposure among the cases. The heterogeneity between the CES and individual effect sizes is also significant. Despite controlling for the confoundings, there is increased exposure to H. pylori among the gastric cancer cases, regardless of the differences in the geographic location. H. pylori in this synthesized literature illustrates the contributory role of this microbe in gastric carcinoma. Additionally, regardless of geographic locale, namely, South Korea or Spain, H. pylori is implicated in gastric cancer development.

Entities:  

Keywords:  Helicobacter pylori (H. pylori); QES; gastric carcinoma; gastric ulceration; gastritis

Year:  2021        PMID: 33466356      PMCID: PMC7824775          DOI: 10.3390/medicines8010001

Source DB:  PubMed          Journal:  Medicines (Basel)        ISSN: 2305-6320


  60 in total

Review 1.  Survival of Helicobacter pylori in gastric acidic territory.

Authors:  Shamshul Ansari; Yoshio Yamaoka
Journal:  Helicobacter       Date:  2017-04-12       Impact factor: 5.753

2.  Meta-analysis in the design and monitoring of clinical trials.

Authors:  R DerSimonian
Journal:  Stat Med       Date:  1996-06-30       Impact factor: 2.373

3.  Meta-analysis in clinical trials.

Authors:  R DerSimonian; N Laird
Journal:  Control Clin Trials       Date:  1986-09

4.  Helicobacter pylori Seropositivity Is Associated with Gastric Cancer Regardless of Tumor Subtype in Korea.

Authors:  Soo-Jeong Cho; Il Ju Choi; Chan Gyoo Kim; Jong Yeul Lee; Myeong-Cherl Kook; Moon-Woo Seong; Sook Ryun Park; Jong Seok Lee; Young-Woo Kim; Keun Won Ryu; Jun Ho Lee; Byung-Ho Nam; Young-Iee Park
Journal:  Gut Liver       Date:  2010-12-17       Impact factor: 4.519

Review 5.  Molecular cross-talk between Helicobacter pylori and human gastric mucosa.

Authors:  Vittorio Ricci; Marco Romano; Patrice Boquet
Journal:  World J Gastroenterol       Date:  2011-03-21       Impact factor: 5.742

6.  Helicobacter pylori vacuolating toxin A and apoptosis.

Authors:  Joachim Rassow
Journal:  Cell Commun Signal       Date:  2011-11-01       Impact factor: 5.712

Review 7.  Bacterial infection as a cause of cancer.

Authors:  J Parsonnet
Journal:  Environ Health Perspect       Date:  1995-11       Impact factor: 9.031

8.  CagA-producing Helicobacter pylori and increased risk of gastric cancer: a nested case-control study in Korea.

Authors:  J Gwack; A Shin; C-S Kim; K-P Ko; Y Kim; J K Jun; J Bae; S K Park; Y-C Hong; D Kang; S-H Chang; H-R Shin; K-Y Yoo
Journal:  Br J Cancer       Date:  2006-08-08       Impact factor: 7.640

9.  Treatment of unicameral bone cyst: systematic review and meta analysis.

Authors:  Muayad Kadhim; Mihir Thacker; Amjed Kadhim; Laurens Holmes
Journal:  J Child Orthop       Date:  2014-02-26       Impact factor: 1.548

10.  The Prevalence of Gastric Intestinal Metaplasia and Distribution of Helicobacter pylori Infection, Atrophy, Dysplasia, and Cancer in Its Subtypes.

Authors:  Sehmus Olmez; Mehmet Aslan; Remzi Erten; Suleyman Sayar; Irfan Bayram
Journal:  Gastroenterol Res Pract       Date:  2015-11-09       Impact factor: 2.260

View more
  5 in total

1.  Comparative Study of Modified Silver Nitrate Staining for the Detection of Helicobacter pylori.

Authors:  Xiaoying Chu; Jian Xu; Li Niu
Journal:  Appl Immunohistochem Mol Morphol       Date:  2022-02-18

2.  Antimicrobial Effect of a Proteolytic Enzyme From the Fruits of Solanum granuloso-leprosum (Dunal) Against Helicobacter pylori.

Authors:  Ángel Gabriel Salinas Ibáñez; Diego Vallés; Mauricio Adaro; Sonia Barberis; Alba E Vega
Journal:  Front Nutr       Date:  2021-12-16

3.  Asclepain cI, a proteolytic enzyme from Asclepias curassavica L., a south American plant, against Helicobacter pylori.

Authors:  Ángel Gabriel Salinas Ibáñez; Anabella L Origone; Constanza S Liggieri; Sonia E Barberis; Alba E Vega
Journal:  Front Microbiol       Date:  2022-08-18       Impact factor: 6.064

4.  Clinical implications of interleukins-31, 32, and 33 in gastric cancer.

Authors:  Qing-Hua Liu; Ji-Wei Zhang; Lei Xia; Steven G Wise; Brett David Hambly; Kun Tao; Shi-San Bao
Journal:  World J Gastrointest Oncol       Date:  2022-09-15

5.  Coinfection of Helicobacter pylori and Hepatitis C Virus in the Development of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.

Authors:  Samragnyi Madala; Kira MacDougall; Balarama Krishna Surapaneni; Robin Park; Mohit Girotra; Anup Kasi
Journal:  J Clin Med Res       Date:  2021-12-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.